The University of Chicago Header Logo

Modulation of irinotecan with cyclosporine: a phase II trial in advanced colorectal cancer.

Modulation of irinotecan with cyclosporine: a phase II trial in advanced colorectal cancer. Cancer Chemother Pharmacol. 2005 Oct; 56(4):421-6.

View in: PubMed